Therapy of trigeminal neuralgia secondary to multiple sclerosis

Expert Review of Neurotherapeutics

Volumn 3, Issue 5, 2003, Pages 661-671

  Leandri, Massimo ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Antiepileptics; Baclofen; Carbamazepine; Lamotrigine; Multiple sclerosis; Phenytoin; Thermorhizotomy; Trigeminal evoked potentials; Trigeminal neuralgia

Indexed keywords

ANTICONVULSIVE AGENT; BACLOFEN; CARBAMAZEPINE; CLONAZEPAM; FELBAMATE; FOSPHENYTOIN SODIUM; GABAPENTIN; LAMOTRIGINE; LIDOCAINE; MUSCLE RELAXANT AGENT; OXCARBAZEPINE; PHENYTOIN; PIMOZIDE; SODIUM CHANNEL BLOCKING AGENT; TOPIRAMATE; VALPROIC ACID;

ANALGESIA; APLASTIC ANEMIA; ATAXIA; CATHETER ABLATION; CLINICAL TRIAL; CONFUSION; DECOMPRESSION SURGERY; DROWSINESS; DRUG EFFICACY; DRUG TOLERABILITY; EVOKED RESPONSE; FLAPPING TREMOR; GAMMA KNIFE RADIOSURGERY; GASTROINTESTINAL SYMPTOM; HUMAN; MULTIPLE SCLEROSIS; MUSCLE WEAKNESS; NEUROTOXICITY; NONHUMAN; NYSTAGMUS; PATHOPHYSIOLOGY; PREVALENCE; RADIOFREQUENCY THERMORHIZOTOMY; RASH; RELIABILITY; REVIEW; RHIZOTOMY; SEDATION; SIDE EFFECT; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; TREATMENT INDICATION; TREMOR; TRIGEMINUS NEURALGIA; VERTIGO;

EID: 0042377117     PISSN: 14737175     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737175.3.5.661     Document Type: Review

References (131)

1. Cruccu G, Berardelli A, Manfredi M. Afferents for the human corneal reflex. J. Neurol. 234, 64 (1987).
2. Cruccu G, Ferracuti S, Leardi MG, Fabbri A, Manfredi M. Nociceptive quality of the orbicularis oculi reflexes as evaluated by distinct opiate- and benzodiazepine-induced changes in man. Brain Res. 556, 209-217 (1991).
3. Leandri M, Gottlieb A, Cruccu G. Head extensor reflex evoked by trigeminal stimulation in humans. Clin. Neurophysiol. 112, 1828-1832 (2001).
4. Young RF. The Trigeminal nerve and its central pathways. Physiology of facial sensation and pain. In: Trigeminal Neuralgia. Rovit RL, Murali R, Jannetta P (Eds). Williams & Wilkins, MD, USA, 27-51 (1990)
5. Task Force on Taxonomy. Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Second Edition. Merskey H, Bogduk N, IASP Press, WA, USA (1994).
6. Selby G. Diseases of the Fifth Cranial Nerve. In: Peripheral Neuropathy (Second Edition). Dick PJ, Thomas PK, Lambert EH, Bunge E (Eds). WB Saunders, PA, USA, 1224-1265 (1984). Excellent review of functional anatomy of the trigeminal nerve, its diseases with pathophysiology, epidemiology and hints at therapy. Although slightly outdated by the third edition of the book, this chapter still retains extremely valuable information of great clarity.
7. Leandri M, Parodi CI, Favale E. Early trigeminal evoked potentials in tumours of the base of the skull and trigeminal neuralgia. Electroencephalogr. Clin. Neurophysiol. 71, 114-124 (1988).
8. Maxwell RE. Clinical diagnosis of trigeminal neuralgia and differential diagnosis of facial pain. In: Trigeminal Neuralgia Rovit RL, Murali R, Jannetta P (Eds). Williams & Wilkins, MD, USA, 53-77 (1990).
9. Meaney JF, Eldridge PR, Dunn LT et al. Demonstration of neurovascular compression in trigeminal neuralgia with magnetic resonance imaging. Comparison with surgical findings in 52 consecutive operative cases. J. Neurosurg. 83, 799-805 (1995).
10. Yoshimasu F, Kurland LT, Elveback LR. Tic douloureux in Rochester, MN, USA, 1945-1969. Neurology 22, 952-956 (1972).
11. Katusic S, Beard CM, Bergstralh E, Kurland LT. Incidence and clinical features of trigeminal neuralgia, Rochester, MN, USA, 1945-1984. Ann. Neurol. 27, 89-95 (1990).
12. Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol. Sci. 22, 117-139 (2001).
13. Pugliatti M, Sotgiu S, Rosati G. The worldwide prevalence of multiple sclerosis. Clin. Neurol. Neurosurg. 104, 182-191 (2002).
14. Rushton JG, Olafson RA. Trigeminal neuralgia associated with multiple sclerosis. A case report. Arch. Neurol. 13, 383-386. (1965).
15. Hooge JP, Redekop WK. Trigeminal neuralgia in multiple sclerosis. Neurology 45, 1294-1296 (1995). Most recent epidemiological study on trigeminal neuralgia occurring in multiple sclerosis patients, thoroughly performed, with hints at therapeutic procedures and their outcomes.
16. Harris W. Rare forms of paroxysmal trigeminal neuralgia and their relation to disseminated sclerosis. Br. Med. J. 2, 1015-1019 (1950).
17. Jensen TS, Rasmussen P, Reske-Nielsen E. Association of trigeminal neuralgia with multiple sclerosis: clinical and pathological features. Acta. Neurol. Scand. 65, 182-189 (1982).
18. Kerr FWL. Evidence for a peripheral etiology of trigeminal neuralgia. J. Neurosurg. 26, 168-174 (1967).
19. King RB. Evidence for a central etiology of tic doloreux. J. Neurosurg. 26, 175-180 (1967).
20. Fromm GH, Terrence CF, Maroon JC. Trigeminal neuralgia. Current concepts regarding etiology and pathogenesis. Arch. Neurol. 41, 1204-1207 (1984).
21. Dubner R, Sharav Y, Gracely RH, Price DD. Idiopathic trigeminal neuralgia: sensory features and pain mechanisms. Pain 31, 23-33 (1987).
22. Rappaport ZH, Devor M. Trigeminal neuralgia: the role of self-sustaining discharge in the trigeminal ganglion. Pain 56, 127-138 (1994). Well thought and soundly based speculation upon the most probable mechanisms of pathophysiology of trigeminal neuralgia. It analyses several characteristics of trigeminal neuralgia, giving very reasonable answers to each question, included the one concerning why some antiepileptics are effective, while pain killers are not.
23. Leandri M, Eldridge P, Miles J. Recovery of nerve conduction following microvascular decompression for trigeminal neuralgia. Neurology 51, 1641-1646 (1998).
24. Love S, Coakham HB. Trigeminal neuralgia: pathology and pathogenesis. Brain 124, 2347-2360 (2001).
25. Love S, Gradidge T, Coakham HB. Trigeminal neuralgia due to multiple sclerosis: ultrastructural findings in trigeminal rhizotomy specimens. Neuropathol. Appl. Neurobiol. 27, 238-244 (2001).
26. Pagni CA. The origin of tic douloureux: a unified view. J. Neurosurg. Sci. 37, 185-194 (1993).
27. Boecher-Schwarz HG, Bruehl K, Kessel G et al. Sensitivity and specificity of MRA in the diagnosis of neurovascular compression in patients with trigeminal neuralgia. A correlation of MRA and surgical findings. Neuroradiology 40, 88-95 (1998).
28. Chang JW, Chang JH, Park YG, Chung SS. Microvascular decompression in trigeminal neuralgia: a correlation of three-dimensional time-of-flight magnetic resonance angiography and surgical findings. Stereotact. Funct. Neurosurg. 74, 167-174 (2000).
29. Akimoto H, Nagaoka T, Nariai T et al. Preoperative evaluation of neurovascular compression in patients with trigeminal neuralgia by use of three-dimensional reconstruction from two types of high-resolution magnetic resonance imaging. Neurosurgery 51, 952-961 (2002).
30. Fukuda H, Ishikawa M, Okumura R. Demonstration of neurovascular compression in trigeminal neuralgia and hemifacial spasm with magnetic resonance imaging: comparison with surgical findings in 60 consecutive cases. Surg. Neurol. 59, 93-100 (2003).
31. Dandy WE. Concerning the cause of trigeminal neuralgia. Am J. Surg. 24, 447-455 (1934).
32. Jannetta PJ. Arterial compression of the trigeminal nerve at the pons in patients with trigeminal neuralgia. J. Neurosurg. 26, 159-162 (1967).
33. Gass A, Kitchen N, MacManus DG et al. Trigeminal neuralgia in patients with multiple sclerosis: lesion localization with magnetic resonance imaging. Neurology 49, 1142-1144 (1997).
34. Nakashima I, Fujihara K, Kimpasa T et al. Linear pontine trigeminal root lesions in multiple sclerosis: clinical and magnetic resonance imaging studies in 5 cases. Arch. Neurol. 58, 101-104 (2001).
35. van der Meijs AH, Tan IL, Barkhof F. Incidence of enhancement of the trigeminal nerve on MRI in patients with multiple sclerosis. Mult. Scler. 8, 64-67 (2002).
36. Cruccu G, Leandri M, Feliciani M, Manfredi M. Idiopathic and symptomatic trigeminal pain. J. Neurol. Neurosurg. Psychiatry 53, 1034-1042 (1990).
37. Leandri M, Favale E. Diagnostic relevance of trigeminal evoked potentials following infraorbital nerve stimulation. J. Neurosurg. 75, 244-250 (1991).
38. Cruccu G, Leandri M, Iannetti GD et al. Small-fiber dysfunction in trigeminal neuralgia: carbamazepine effect on laser-evoked potentials. Neurology 56, 1722-1726 (2001).
39. Gardner WJ, Miklos MV. Response of trigeminal neuralgia to decompression of sensory root. Discussion of cause of trigeminal neuralgia. JAMA 170, 1773-1776 (1959).
40. Barker FG, 2nd, Jannetta PJ, Bissonette DJ, Larkins MV, Jho HD. The long-term outcome of microvascular decompression for trigeminal neuralgia. N. Engl. J. Med. 334, 1077-1083 (1996).
41. Meaney JF, Watt JW, Eldridge PR et al. Association between trigeminal neuralgia and multiple sclerosis: role of magnetic resonance imaging. J. Neurol. Neurosurg. Psychiatry 59, 253-259 (1995).
42. Broggi G, Ferroli P, Franzini A et al. Role of microvascular decompression in trigeminal neuralgia and multiple sclerosis. Lancet 354, 1878-1879 (1999). Strongly supports the view that even in multiple sclerosis, vascular compression of the trigeminal root plays a key role in generating the neuralgic pain. This author finds that there are many objections and strongly disagrees with that view. However, it is a paper that merits attention by the inquisitive mind.
43. Broggi G, Ferroli P, Franzini A, Servello D, Dones I. Microvascular decompression for trigeminal neuralgia: comments on a series of 250 cases, including 10 patients with multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 68, 59-64 (2000).
44. Resnick DK, Jannetta PJ, Lunsford LD, Bissonette DJ. Microvascular decompression for trigeminal neuralgia in patients with multiple sclerosis. Surg. Neurol 46, 358-361 (1996). This paper is by the research group that most popularized the microvascular decompression surgery for trigeminal neuralgia. Its conclusion is against the use of this procedure in multiple sclerosis patients with trigeminal neuralgia.
45. Adams CB. Microvascular compression: an alternative view and hypothesis. J. Neurosurg. 70, 1-12 (1989). One of the most relevant, detailed and recent criticisms to the rationale underlying microvascular decompression for TGN. The author provides convincing arguments that, however, have been in part outdated and contradicted by subsequent neurophysiological findings.
46. Bergouignan M. Cures heureuses de névralgies faciales essentelles par le diphenyl-hydantoinate de soude. Rev. Laryngol. Otol. Rhinol. 63, 34-41 (1942).
47. Macdonald RL. Carbamazepine. Mechanisms of Action. In: Antiepileptic Drugs Fourth Edition. Levy RH, Mattson RH, Meldrum BS (Eds). Raven Press, NY, USA, 491-498 (1995).
48. Blom S. Trigeminal neuralgia: its treatment with a new anticonvulsant drug (G-328883). Lancet 1, 829-849 (1962).
49. Fields HL. Treatment of trigeminal neuralgia. N. Engl. J. Med. 334,1125-1126 (1996).
50. Cheshire WP. Trigeminal neuralgia. A guide to drug choice. CNS Drugs 7, 98-110 (1997). Comprehensive and still updated review of available medical therapies for trigeminal neuralgia.
51. Tomson T, Tybring G, Bertilsson L, Ekbom K, Rane A. Carbamazepine therapy in trigeminal neuralgia: clinical effects in relation to plasma concentration. Arch. Neurol. 37, 699-703 (1980).
52. Tomson T, Tybring G, Bertilsson L, Ekbom K, Rane A. Carbamazepine in trigeminal neuralgia: clinical effects in relation to plasma-concentration. Ups. J. Med. Sci. Suppl. 31, 45-46 (1980).
53. Hunter SF, Lim N, Nashville TN. Carbamazepine (CBZ)-induced exacerbation of weakness in severe demyelinating disease. Neurology 52 (S2), A135 (1999).
54. Leach MJ, Lees G, Dieter RR. Lamotrigine. Mechanisms of action. In: Antiepileptic Drugs. Fourth Edition. Levy RH, Mattson RH, Meldrum BS (Eds). Raven Press, NY, USA, 861-869 (1995).
55. Canavero S, Bonicalzi V, Ferroli P et al. Lamotrigine control of idiopathic trigeminal neuralgia. J. Neurol. Neurosurg. Psychiatry 59, 646 (1995).
56. Canavero S, Bonicalzi V. Lamotrigine control of trigeminal neuralgia: an expanded study. J. Neurol. 244, 527 (1997).
57. Lunardi G, Leandri M, Albano C et al. Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. Neurology 48, 1714-1717 (1997).
58. Zakrzewska JM, Chaudhry Z, Nurmikko TJ, Patton DW, Mullens EL. Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo-controlled crossover trial. Pain 73, 223-230 (1997).
59. Leandri M, Lunardi G, Inglese M et al. Lamotrigine in trigeminal neuralgia secondary to multiple sclerosis. J. Neurol. 247, 556-558 (2000).
60. Solaro C, Messmer Uccelli M, Uccelli A, Leandri M, Mancardi GL. Low-dose gabapentin combined with either lamotrigine or carbamazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis. Eur. Neurol 44, 45-48 (2000).
61. Kut H. Phenytoin. Interactions with other drugs: clinical aspects. In: Antiepileptic Drugs. Fourth Edition. Levy RH, Mattson RH, Meldrum BS (Eds). Raven Press, NY, USA, 315-328 (1995).
62. Bruni J. Phenytoin. Toxicity. In: Antiepileptic Drugs. Fourth Edition. Levy RH, Mattson RH, Meldrum BS (Eds). Raven Press, NY, USA, 345-350 (1995).
63. Kangrga I, Jiang MC, Randic M. Actions of (-)-baclofen on rat dorsal horn neurons. Brain Res. 562, 265-275 (1991).
64. Fromm GH, Terrence CF, Chattha AS, Glass JD. Baclofen in trigeminal neuralgia: its effect on the spinal trigeminal nudeus: a pilot study. Arch. Neurol. 37, 768-771 (1980).
65. Fromm GH, Terrence CF, Chattha AS. Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up. Ann Neurol. 15, 240-244 (1984).
66. Steardo L, Leo A, Marano E. Efficacy of baclofen in trigeminal neuralgia and some other painful conditions. A clinical trial. Eur. Neurol. 23, 51-55 (1984).
67. Parmar BS, Shah KH, Gandhi IC. Baclofen in trigeminal neuralgia-a clinical trial. Indian J. Dent. Res. 1, 109-113 (1989).
68. Dam M, Ostergaard LH. Other Antiepileptic drugs. Oxcarbazepine. In: Antiepileptic Drugs Levy RH, Mattson RH, Meldrum BS (Eds). Raven Press, NY, USA, 987-995 (1995)
69. Zakrzewska JM, Patsalos PN. Oxcarbazepine: a new drug in the management of intractable trigeminal neuralgia. J. Neurol. Neurosurg. Psychiatry 52, 472-476 (1989).
70. Zakrzewska JM, Patsalos PN. Long-term cohort study comparing medical (oxcarbazepine) and surgical management of intractable trigeminal neuralgia. Pain 95, 259-266 (2002).
71. Beydoun A, Kutluay E. Oxcarbazepine. Exp. Opin. Pharmacother. 3, 59-71 (2002).
72. Fariello RG, Varasi M, Smith MC. Valproic acid. Mechanisms of action. In: Antiepileptic drugs. Fourth Edition. Levy RH, Mattson RH, Meldrum BS (Eds). Raven Press, NY, USA (1995)
73. Peiris JB, Perera GL, Devendra SV, Lionel ND. Sodium valproate in trigeminal neuralgia. Med. J. Aust. 2, 278 (1980).
74. Dreifuss FE. Valproic acid. Toxicity. In: Antiepileptic Drugs. Fourth Edition. Levy E, Mattson RH, Meldrum BS (Eds). Raven Press, NY, USA, 641-648 (1995)
75. Merren MD. Gabapentin for treatment of pain and tremor: a large case series. South Med. J. 91, 739-744 (1998).
76. Valzania F, Strafella AP, Nassetti SA. Gabapentin for idiopathic trigeminal neuralgia. Neurology 50, A379 (1998).
77. Cheshire W. Defining the role for gabapentin in the treatment of trigeminal neuralgia: a retrospective study. J. Pain 3, 137-142 (2002).
78. Khan OA. Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients. Neurology 51, 611-614 (1998).
79. Solaro C, Lunardi GL, Capello E et al. An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients. Neurology 51, 609-611 (1998).
80. D'Aleo G, Rifici C, Sessa E, Di Bella P, Bramanti P. R3 nocicepdve reflex in multiple sclerosis patients with paroxysmal symptoms treated with gabapentin. Funct. Neurol. 15, 205-209 (2000).
81. Ben-Menachem E. Potential antuiepileptic drugs. Topiramate. In: Antiepileptic drugs. Fourth Edition. Levy RH, Mattson RH, Meldrum BS (Eds). Raven Press, NY, USA, 1063-1070 (1995).
82. Zvartau-Hind M, Din MU, Gilani A, Lisak RP, Khan OA. Topiramate relieves refractory trigeminal neuralgia in MS patients. Neurology 55, 1587-1588 (2000).
83. Gilron I, Booher SL, Rowan JS, Max MB. Topiramate in trigeminal neuralgia: a randomized, placebo-controlled multiple crossover pilot study. Clin. Neuropharmacol. 24, 109-112 (2001).
84. Cheshire WP. Felbamate relieved trigeminal neuralgia. Clin. J. Pain 11, 139-142 (1995).
85. Caccia MR. Clonazepam in facial neuralgia and duster headache. Clinical and electrophysiological study. Eur. Neurol. 13, 560-563 (1975).
86. Chandra B. The use of clonazepam in the treatment of tic douloureux (a preliminary repon). Proc. Aust. Assoc. Neurol. 13, 119-122 (1976).
87. Court JE, Kase CS. Treatment of tic douloureux with a new anticonvulsant (donazepam). J. Neurol. Neurosurg. Psychiatry 39, 297-299 (1976).
88. Smirne S, Scarlato G. Clonazepam in cranial neuralgias. Med. J. Aust. 1, 93-94 (1977).
89. Lechin F, van der Dijs B, Lechin ME et al. Pimozide therapy for trigeminal neuralgia. Arch. Neurol. 46, 960-963 (1989).
90. Ecker A. Pimozide therapy for trigeminal neuralgia. Arch. Neurol. 47, 382 (1990).
91. Kugelberg E, Lindblom U. The mechanism of pain in trigeminal neuralgia. J. Neurol. Neurosurg. Psychiatry 22, 36-43 (1959).
92. Wilder BJ. Phenytoin. Clinical use. In: Antiepileptic Drugs. Second Edition. Levy El, Mattson RH, Meldrum BS (Eds). Raven Press, NY, USA, 339-344 (1995)
93. Cheshire WP. Fosphenytoin: an intravenous option for the management of acute trigeminal neuralgia crisis. J. Pain Symptom Manage. 21, 506-510 (2001).
94. Kondziolka D, Lunsford LD, Bissonette DJ. Long-term results after glycerol rhizotomy for multiple sclerosis-related trigeminal neuralgia. Can. J. Neurol. Sci. 21, 137-140 (1994).
95. Kirschner M. Die Punktionstechnik und die Elektrokoagulation des Ganglion Gasseri. Arch. Klin. Chir. 176, 581 (1933).
96. Sweet WH, Wepsic JG. Controlled thermocoagulation of trigeminal ganglion and rootlets for differential destruction of pain fibers. I. Trigeminal neuralgia. J. Neurosurg. 40, 143-156 (1974).
97. Sweet WH. The treatment of trigeminal neuralgia (tic douloureux). N. Engl. J. Med. 315, 174-177 (1986). Authoritative, well-balanced review mainly aimed at surgical therapy by one of the authors who perfected the radiofrequency thermolesion, perhaps the most widely used surgery for trigeminal neuralgia. Although published more than 15 years ago, it is still a useful reference to know pros and cons of surgical procedures.
98. Yoon KB, Wiles JR, Miles JB, Nurmikko TJ. Long-term outcome of percutaneous thermocoagulation for trigeminal neuralgia. Anaesthesia 54, 803-808 (1999).
99. Siegfried J. 500 percutaneous thermocoagulations of the gasserian ganglion for trigeminal pain. Surg. Neurol. 8, 126-131 (1977).
100. Brett DC, Ferguson GG, Ebers GC, Paty DW. Percutaneous trigeminal rhizotomy. Treatment of trigeminal neuralgia secondary to multiple sclerosis. Arch. Neurol. 39, 219-221 (1982).
101. Brisman R. Trigeminal neuralgia and multiple sclerosis. Arch. Neurol. 44, 379-381 (1987).
102. Leandri M, Parodi CI, Favale E. Early evoked potentials detected from the scalp of man following infraorbital nerve stimulation. Electroencephalogr. Clin. Neurophysiol. 62, 99-107 (1985).
103. Leandri M, Campbell JA. Origin of early waves evoked by infraorbital nerve stimulation in man. Electroencephalogr. Clin. Neurophysiol. 65, 13-19 (1986).
104. Leandri M, Gottlieb A. Trigeminal evoked potential-monitored thermorhizotomy: a novel approach for relief of trigeminal pain. J. Neurosurg. 84, 929-939 (1996). Describes how the radiofrequency thermorhizotomy can be performed with the sole aid of electrophysiological monitoring under sustained anesthesia. Precise lesions can be performed with little sensory loss, at the price of a surgical procedure made more complicated by the massive participation of the neurophysiologist.
105. Hakanson S. Trigeminal neuralgia treated by the injection of glycerol into the trigeminal cistem. Neurosurgery 9, 638-646 (1981).
106. Sweet WH, Poletti CE. Problems with retrogasserian glycerol in the treatment of trigeminal neuralgia. Appl. Neurophysiol. 48, 252-257 (1985).
107. Brown JA, Hoeflinger B, Long PB et al. Axon and ganglion cell injury in rabbits after percutaneous trigeminal balloon compression. Neurosurgery 38, 993-1004 (1996).
108. Brown JA, Gouda JJ. Percutaneous balloon compression of the trigeminal nerve. Neurosurg. Clin. N. Am. 8, 53-62 (1997).
109. Mullan S, Lichtor T. Percutaneous microcompression of the trigeminal ganglion for trigeminal neuralgia. J. Neurosurg. 59, 1007-1012 (1983).
110. Zanusso M, Curri D, Landi A et al. Pressure monitoring inside Meckel's cave during percutaneous microcompression of gasserian ganglion. Stereotact. Funct. Neurosurg. 56, 37-43 (1991).
111. Landi A, Zanusso M, Curri D, Colombo F, Benedetti A. Trigeminal evoked potentials in patients undergoing percutaneous microcompression of gasserian ganglion. Stereotact. Funct. Neurosurg. 56, 28-36 (1991).
112. Brown JA, Preul MC. Trigeminal depressor response during percutaneous microcompression of the trigeminal ganglion for trigeminal neuralgia. Neurosurgery 23, 745-748 (1988).
113. Mefflo M, God B, Moles A, Visocchi M. Microvascular decompression versus percutaneous procedures for typical trigeminal neuralgia: personal experience. Stereotact. Funct. Neurosurg. 54-55, 76-79 (1990).
114. Fraioli B, Esposito V, Guidetti B, Cruccu G, Manfredi M. Treatment of trigeminal neuralgia by thermocoagulation, glycerolization and percutaneous compression of the gasserian ganglion and/or retrogasserian rootlets: long-term results and therapeutic protocol. Neurosurgery 24, 239-245 (1989).
115. Brown JA, McDaniel MD, Weaver MT. Percutaneous trigeminal nerve compression for treatment of trigeminal neuralgia: results in 50 patients. Neurosurgery 32, 570-573 (1993).
116. Belber CJ, Rak RA. Balloon compression rhizolysis in the surgical management of trigeminal neuralgia. Neurosurgery 20, 908-913 (1987).
117. Brown JA, Preul MC. Percutaneous trigeminal ganglion compression for trigeminal neuralgia. Experience in 22 patients and review of the literature. J. Neurosurg. 70, 900-904 (1989).
118. Lichtor T, Mullan JF. A 10-year follow-up review of percutaneous microcompression of the trigeminal ganglion. J. Neurosurg. 72, 49-54 (1990).
119. Lobato RD, Rivas JJ, Sarabia R, Lamas E. Percutaneous microcompression of the gasserian ganglion for trigeminal neuralgia. J. Neurosurg. 72, 546-553 (1990).
120. Abdennebi B, Bouatta F, Chitti M, Bougatene B. Percutaneous balloon compression of the Gasserian ganglion in trigeminal neuralgia. Long-term results in 150 cases. Acta. Neurochir. (Wien) 136, 72-74 (1995).
121. Abdennebi B, Mahfouf L, Nedjahi T. Long-term results of percutaneous compression of the gasserian ganglion in trigeminal neuralgia (series of 200 patients). Stereotact. Funct. Neurosurg. 68, 190-195 (1997).
122. Correa CF, Teixeira MJ. Balloon compression of the Gasserian ganglion for the treatment of trigeminal neuralgia. Stereotact. Funct. Neurosurg. 71, 83-89 (1998).
123. Skirving DJ, Dan NG. A 20-year review of percutaneous balloon compression of the trigeminal ganglion. J. Neurosurg. 94, 913-917 (2001).
124. Kondziolka D, Lacomis D, Niranjan A et al. Histological effects of trigeminal nerve radiosurgery in a primate model: implications for trigeminal neuralgia radiosurgery Neurosurgery 46, 971-977 (2000).
125. Rogers CL, Shetter AG, Ponce FA et al. Gamma knife radiosurgery for trigeminal neuralgia associated with multiple sclerosis. J. Neurosurg. 97, 529-532 (2002).
126. Urgosik D, Vymazal J, Vladyka V, Liscak R. Gamma knife treatment of trigeminal neuralgia: clinical and electrophysiological study. Stereotact. Funct. Neurosurg. 70(Suppl. 1), 200-209 (1998).
127. Waxman SG, Dib-Hajj S, Cummins TR, Black JA. Sodium channels and pain. Proc. Natl. Acad. Sci. USA 96, 7635-7639 (1999).
128. Novakovic SD, Tzoumaka E, McGivern JG et al. Distribution of the tetrodotoxin-resistant sodium channel PN3 in rat sensory neurons in normal and neuropathic conditions. J. Neurosci. 18, 2174-2187 (1998).
129. Novakovic SD, Eglen RM, Hunter JC. Regulation of Na+ channel distribution in the nervous system. Trends Neurosci. 24, 473-478 (2001).
130. Veneroni O, Maj R, Calabresi M et al. Antiallodynic effect of NW-1029, a novel Na(+) channel blocker, in experimental animal models of inflammatory and neuropathic pain. Pain 102, 17-25 (2003).
131. Laird JM, Carter AJ, Grauert M, Cervero F. Analgesic activity of a novel use-dependent sodium channel blocker, crobenetine, in mono-arthritic rats. Br. J. Pharmacol. 134, 1742-1748 (2001).